Ying Cui Selected Research

Cerebral Hemorrhage

3/2019	Lipoxin A4 Methyl Ester Reduces Early Brain Injury by Inhibition of the Nuclear Factor Kappa B (NF-κB)-Dependent Matrix Metallopeptidase 9 (MMP-9) Pathway in a Rat Model of Intracerebral Hemorrhage.
3/2018	Recombinant Osteopontin Improves Neurological Functional Recovery and Protects Against Apoptosis via PI3K/Akt/GSK-3β Pathway Following Intracerebral Hemorrhage.
4/2017	Intraparenchymal treatment with bone marrow mesenchymal stem cell-conditioned medium exerts neuroprotection following intracerebral hemorrhage.
1/2017	Bone Marrow Mesenchymal Stem Cell Transplantation Increases GAP-43 Expression via ERK1/2 and PI3K/Akt Pathways in Intracerebral Hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Cui Research Topics

Disease

67	Neoplasms (Cancer) 02/2022 - 11/2007
26	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2008
17	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2011
10	Carcinogenesis 01/2022 - 09/2009
10	Atherosclerosis 02/2021 - 01/2013
9	Infections 01/2022 - 01/2015
9	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017 - 01/2014
8	Breast Neoplasms (Breast Cancer) 04/2022 - 04/2008
8	Inflammation (Inflammations) 01/2020 - 04/2014
6	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2022 - 12/2020
6	Lung Neoplasms (Lung Cancer) 01/2020 - 02/2007
6	Brain Edema (Cerebral Edema) 03/2019 - 08/2015
5	Ischemic Stroke 01/2022 - 01/2018
5	Colonic Neoplasms (Colon Cancer) 01/2022 - 07/2014
5	Carcinoma (Carcinomatosis) 12/2021 - 03/2005
5	Stroke (Strokes) 01/2021 - 03/2015
5	Brain Injuries (Brain Injury) 03/2019 - 01/2013
4	Epilepsy (Aura) 10/2022 - 01/2019
4	Chronic Renal Insufficiency 02/2022 - 12/2018
4	Hypoxia (Hypoxemia) 01/2021 - 11/2013
4	Brain Ischemia (Cerebral Ischemia) 12/2020 - 08/2015
4	Fibrosis (Cirrhosis) 01/2020 - 09/2013
4	Necrosis 12/2019 - 04/2017
4	Cerebral Hemorrhage 03/2019 - 01/2017
4	Glucose Intolerance 01/2019 - 08/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 07/2018 - 07/2014
3	Insulin Resistance 01/2022 - 01/2013
3	Secondary Hyperparathyroidism 11/2021 - 12/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2018
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2014
3	Cognitive Dysfunction 01/2021 - 01/2019
3	Glioma (Gliomas) 10/2020 - 06/2011
3	Liver Neoplasms (Liver Cancer) 09/2019 - 11/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2019 - 11/2014
3	Coronary Disease (Coronary Heart Disease) 01/2017 - 03/2011
3	Nasopharyngeal Carcinoma 10/2015 - 02/2010
2	Rheumatoid Arthritis 01/2022 - 02/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2016
2	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 11/2020
2	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 01/2014
2	Hyperglycemia 10/2021 - 01/2019
2	Postpartum Depression (Post-Natal Depression) 09/2021 - 12/2003
2	Ganglion Cysts (Ganglion) 01/2021 - 11/2020
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 11/2020
2	Ulcerative Colitis 01/2021 - 09/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2014
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2009
10	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2014
7	Biological ProductsIBA 01/2022 - 01/2013
7	Neuroprotective AgentsIBA 03/2018 - 05/2014
6	Therapeutic UsesIBA 01/2022 - 01/2013
6	Pharmaceutical PreparationsIBA 01/2022 - 12/2007
6	CytokinesIBA 01/2021 - 05/2015
5	Long Noncoding RNAIBA 10/2022 - 01/2018
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 08/2011
4	Retinaldehyde (Retinal)IBA 01/2022 - 11/2020
4	Messenger RNA (mRNA)IBA 01/2021 - 09/2009
4	EnzymesIBA 01/2020 - 12/2008
4	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2015
4	Interleukin-8 (Interleukin 8)IBA 06/2019 - 01/2013
4	Indicators and Reagents (Reagents)IBA 01/2019 - 10/2015
4	Small Interfering RNA (siRNA)IBA 02/2016 - 09/2009
3	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 09/2015
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 10/2016
3	Competitive Endogenous RNAIBA 01/2022 - 08/2018
3	NitrogenIBA 01/2022 - 12/2019
3	CateninsIBA 01/2022 - 09/2020
3	Parathyroid Hormone (Parathormone)IBA 11/2021 - 01/2018
3	Becaplermin (PDGF-BB)FDA Link 01/2021 - 08/2014
3	Apolipoproteins E (ApoE)IBA 01/2021 - 04/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
3	Oxygen (Dioxygen)IBA 01/2021 - 04/2018
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2011
3	Hormones (Hormone)IBA 10/2020 - 07/2018
3	Matrix Metalloproteinases (MMPs)IBA 09/2020 - 11/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2011
3	CalciumIBA 07/2018 - 03/2016
3	RNA (Ribonucleic Acid)IBA 01/2018 - 09/2009
3	Peptides (Polypeptides)IBA 10/2017 - 01/2013
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 04/2022 - 01/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 01/2022
2	AnticoagulantsIBA 01/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 12/2021 - 01/2019
2	catalpolIBA 10/2021 - 10/2014
2	Antidepressive Agents (Antidepressants)IBA 10/2021 - 10/2014
2	Tuberculin (PPD)IBA 09/2021 - 12/2003
2	Laminin ReceptorsIBA 07/2021 - 01/2017
2	pigment epithelium-derived factorIBA 07/2021 - 01/2017
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2021 - 06/2019
2	CollagenIBA 01/2021 - 11/2014
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 12/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2013
2	Sirtuin 1IBA 12/2020 - 02/2016

Therapy/Procedure

25	Therapeutics 01/2022 - 08/2009
7	Radiotherapy 04/2022 - 02/2007
6	Drug Therapy (Chemotherapy) 01/2018 - 08/2009
5	Parathyroidectomy 02/2022 - 12/2018
4	Transplantation 01/2017 - 01/2013
2	Immunotherapy 01/2022 - 05/2014